NCT02122926
Completed
N/A
Effects of an Intensive Discharge Intervention on Medication Adherence, Glycemic Control, and Readmission Rates in Patients With Type 2 Diabetes
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Type II Diabetes
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 180
- Locations
- 1
- Primary Endpoint
- Cardiac medication adherence
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
The goal of this study is to design and implement an intensive discharge intervention for inpatients with type 2 diabetes and cardiovascular disease, and determine the effects of the intervention on post-discharge insulin adherence, glycemic control, cardiac medication adherence, hypoglycemic events, and emergency department visits and hospital readmissions.
Investigators
Jeffrey L. Schnipper, MD.,MPH.
Associate Professor of Medicine
Brigham and Women's Hospital
Eligibility Criteria
Inclusion Criteria
- •Adult inpatients at BWH on the medicine or cardiology services with a primary care physician who belongs to a participating practice or has not explicitly opted out of the study
- •Type 2 diabetes
- •Active cardiovascular disease
- •Likely to be discharged home, and one of the following:
- •prescribed insulin prior to admission
- •prescribed two oral agents and with an A1c \> 8.0 within 30 days of admission. - Practices that have already agreed to participate in this study for all their eligible patients.
Exclusion Criteria
- •Discharge to a location other than home or rehabilitation (or to a caregiver's home)
- •Patient does not administer own medications and absence of a caregiver who lives with patient and administers all medications
- •Police custody, no telephone or homeless
- •Previous enrolment in the study within 90 days of discharge
- •Patient unable to communicate in either English or Spanish
- •Participation in the Integrated Care Management Program (iCMP)
Outcomes
Primary Outcomes
Cardiac medication adherence
Time Frame: 30 days after discharge
Cardiac medication adherence as determined by patient self report 30 days after discharge
Secondary Outcomes
- Glycemic control(90 days after discharge)
- Emergency department visits(Within 30 days after discharge)
- Number of self-reported hypoglycemic events(Within 30 days of discharge)
- Number of patient-days with hypoglycemia(Within 30 days of discharge)
- Cardiac medication adherence(90 days after discharge)
- Hospital Readmissions(Within 30 days of discharge)
Study Sites (1)
Loading locations...
Similar Trials
Completed
N/A
Nurse Assisted Post-discharge Intervention in Decompensated CirrhosisLiver CirrhosisNCT04158986Copenhagen University Hospital, Hvidovre110
Enrolling by Invitation
N/A
Analysis of the Virtual Acute Care at Home ExperienceConditionsInfectionsHeart FailureRenal and Urinary DisordersDiabetesHypertensionFeverBronchitisAsthma, Chronic Obstructive Pulmonary Disease (COPD)NCT05952999OSF Healthcare System9,654
Completed
Phase 3
An Intervention to Improve Outcomes in Patients With Advanced CancerCancerNCT01272024Yale University146
Enrolling by Invitation
N/A
Discharge Planning Program for Post CABG PatientsCoronary Artery Bypass Graft SurgeryMace30 Day MortalityNCT04527822University of Jordan174
Completed
N/A
Comprehensive Intervention to Evaluate Outcomes AND Cost in Hospitalized Surgical Patients With Diabetes Mellitus (DM)DiabetesNCT02065050Brigham and Women's Hospital220